Cholesterol crystal embolization: A possible complication of peripheral endovascular interventions

Journal of Endovascular Therapy

Volumn 15, Issue 5, 2008, Pages 614-625

  Paraskevas, Kosmas I ^a,b   Koutsias, Stylianos ^c   Mikhailidis, Dimitri P ^a   Giannoukas, Athanasios D ^c  

^a ROYAL FREE AND UNIVERSITY COLLEGE MEDICAL SCHOOL   (United Kingdom)

^b RED CROSS HOSPITAL   (Greece)

^c UNIVERSITY HOSPITAL OF LARISSA   (Greece)

Author keywords

Aortoiliac occlusive disease; Cholesterol crystal embolization; Endovascular aneurysm repair; Endovascular interventions

Indexed keywords

ATORVASTATIN; CHOLESTEROL; CORTICOSTEROID; CREATININE; CYCLOPHOSPHAMIDE; ILOPROST; METHYLPREDNISOLONE; NITROGEN; PRAVASTATIN; PREDNISOLONE; PREDNISONE; SIMVASTATIN; UREA; WARFARIN;

ANGIOGRAPHY; ANTICOAGULATION; APHERESIS; ARTERY OCCLUSION; CHOLESTEROL EMBOLISM; CLINICAL FEATURE; CONTINUOUS INFUSION; DIFFERENTIAL DIAGNOSIS; DRUG DOSE INCREASE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; EARLY DIAGNOSIS; ENDOVASCULAR SURGERY; ERYTHROCYTE SEDIMENTATION RATE; HEMATURIA; HISTOPATHOLOGY; HUMAN; KIDNEY BIOPSY; KIDNEY DYSFUNCTION; LIVEDO RETICULARIS; MORBIDITY; MORTALITY; MUSCLE BIOPSY; PRIORITY JOURNAL; PROTEINURIA; REVIEW; RISK REDUCTION; SKIN BIOPSY; TREATMENT OUTCOME;

EMBOLISM, CHOLESTEROL; HUMANS; VASCULAR SURGICAL PROCEDURES;

EID: 56349139624     PISSN: 15266028     EISSN: None     Source Type: Journal    
DOI: 10.1583/08-2395.1     Document Type: Review

References (132)

1. Donohue KG, Saap L, Falanga V. Cholesterol crystal embolization: an atherosclerotic disease with frequent and varied cutaneous manifestations. J Eur Acad Dermatol Venereol. 2003;17:504-511.
2. Kassirer JP. Atheroembolic renal disease. N Engl J Med. 1969;280:812-818.
3. Fine MJ, Kapoor W, Falanga V. Cholesterol crystal embolization: a review of 221 cases in the English literature. Angiology. 1987;38: 769-784.
4. Ramirez G, O'Neill WM, Lambert R, et al. Cholesterol embolization: a complication of angiography. Arch Intern Med. 1978;138: 1430-1432.
5. Jucgla A, Moreso F, Muniesa C, et al. Cholesterol embolism: still an unrecognised entity with a high mortality rate. J Am Acad Dermatol. 2006;55:786-793.
6. Cross SS. How common is cholesterol embolism? J Clin Pathol. 1991;44:859-861.
7. Kealy WF. Atheroembolism. J Clin Pathol. 1978;31:984-989.
8. Gore I, Collins DP. Spontaneous atheromatous embolization. Review of the literature and a report of 16 additional cases. Am J Clin Pathol. 1960;33:416-426.
9. Zuccala A, Zucchelli P. A renal disease frequently found postmortem, but rarely diagnosed in vivo. Nephrol Dial Transplant. 1997;12:1762-1767.
10. Thurlbeck WM, Castleman B. Atheromatous emboli to the kidneys after aortic surgery. N Engl J Med. 1957;257:442-447.
11. Geroulakos G, Homer-Vanniasinkam S, Wilkinson A, et al. Cholesterol embolisation. A lethal embolisation of instrumentation of an aneurysmal aorta: case report. Int Angiol. 1997;16:69-71.
12. Jaeger HJ, Mathias KD, Gissler HM, et al. Rectum and sigmoid colon necrosis due to cholesterol embolization after implantation of an aortic stent-graft. J Vasc Interv Radiol. 1999;10:751-755.
13. Marty B, Perruchoud C, Wicky S, et al. Atheroembolization: a harmful complication of therapeutic internal iliac artery occlusion. J Vasc Surg. 2002;36:1062-1065.
14. Carrocio A, Olin JW, Ellozy SH, et al. The role of aortic stent grafting in the treatment of atheromatous embolization syndrome: results after a mean of 15 months follow-up. J Vasc Surg. 2004;40:424-429.
15. Fukumoto Y, Tsutsui H, Tsuchihashi M, et al. The incidence and risk factors of cholesterol embolization syndrome, a complication of cardiac catheterization: a prospective study. J Am Coll Cardiol. 2003;42:211-216.
16. Scolari F, Bracchi M, Valzorio B, et al. Cholesterol atheromatous embolism: an increasingly recognized cause of acute renal failure. Nephrol Dial Transplant. 1996;11: 1607-1612.
17. Meyrier A. Cholesterol crystal embolism: diagnosis and treatment. Kidney Int. 2006;69: 1308-1312.
18. Panum PL. Experimentelle beitrage zur lehre von der embolie. Virchows Arch (Pathol Anat). 1862;25:308-338.
19. Flory CM. Arterial occlusions produced by emboli from eroded aortic atheromatous plaques. Am J Pathol. 1945;21:549-565.
20. Zak FG, Elias K. Embolization with material from atheromata. Am J Med Sci. 1949;218: 510-515.
21. Schornagel HE. Emboli of cholesterol crystals. J Pathol Bacteriol. 1961;81:119-122.
22. Maurizi CP, Barker AE, Trueheart RE. Atheromatous emboli: a postmortem study with special reference to the lower extremities. Arch Pathol. 1968;86:528-534.
23. Dupont PJ, Lightstone L, Clutterbuck EJ, et al. Lesson of the week: cholesterol emboli syndrome. BMJ. 2000;321:1065-1067.
24. Moolenaar W, Lamers CB. Cholesterol crystal embolization in the Netherlands. Arch Intern Med. 1996;156:653-657.
25. Moolenaar W, Lamers CB. Cholesterol crystal embolization to the alimentary canal. Gut. 1996;38:196-200.
26. Preston RA, Stemmer CL, Materson BJ, et al. Renal biopsy in patients 65 years of age or older. An analysis of the results of 334 biopsies. J Am Geriatr Soc. 1990;38:669-674.
27. Frock J, Bierman M, Hammeke M, et al. Atheroembolic renal disease: experience with 22 patients. Nebr Med J. 1994;79:317-321.
28. Mayo RR, Swartz RD. Redefining the incidence of clinically detectable atheroembolism. Am J Med. 1996;100:524-529.
29. Lie JT. Cholesterol atheromatous embolism. The great masquerader revisited. Pathol Annu. 1992;27:17-50.
30. Zaytsev P, Miller K, Pellettiere EV. Cutaneous cholesterol emboli with infarction clinically mimicking heparin necrosis - a case report. Angiology. 1986;37:471-476.
31. Richards AM, Eliot RS, Kanjuh VI, et al. Cholesterol embolism: a multiple-system disease masquerading as polyarteritis nodosa. Am J Cardiol. 1965;15:696-707.
32. Badawi G, Jebara VA, el Rassi I, et al. Spontaneous cholesterol embolization. A rarely reported entity. Tex Heart Inst J. 1994; 21:228-230.
33. Lonni Y, Matsumoto K, Lecky JW. Postaortographic cholesterol (atheromatous) embolization. Radiology. 1969;93:63-65.
34. Drost H, Buis B, Haan D, et al. Cholesterol embolism as a complication of left heart catheterisation. Report of seven cases. Br Heart J. 1984;52:339-342.
35. Harrington D, Amplatz K. Cholesterol embolization and spinal infarction following aortic catheterization. Am J Roentgenol Radium Ther Nucl Med. 1972;115:171-174.
36. Henderson MJ, Manhire AR. Cholesterol embolization following angiography. Clin Radiol. 1990;42:281-282.
37. Belli AM, Cumberland DC, Knox AM, et al. The complication rate of peripheral balloon angioplasty. Clin Radiol. 1990;41:380-383.
38. Piriou V, Claudel JP, Bastien O, et al. Severe systemic cholesterol embolization after open heart surgery. Br J Anaesth. 1996;77:277-280.
39. Vazquez-Jimenez JF, Perez-Bouza A, Liakopoulos OJ, et al. Cholesterol crystal embolization after cardiac operations. Report of two cases. Eur J Cardiothorac Surg. 2001;19:96-98.
40. Izumi C, Kondo H, Tamura T, et al. Clinical evaluation of cholesterol embolization syndrome after cardiac catheterization. J Cardiol. 1998;31:201-206.
41. Belenfant X, D'Auzac C, Bariety J, et al. Cholesterol crystal embolism during treatment with low-molecular-weight heparin. Presse Med. 1997;26:1236-1237.
42. Gupta BK, Spinowitz BS, Charytan C, et al. Cholesterol crystal embolization-associated renal failure after therapy with recombinant tissue-type plasminogen activator. Am J Kidney Dis. 1993;21:659-662.
43. Rivera-Manrique E, Castro-Salomo A, Azon-Masoliver A, et al. Cholesterol embolism: a fatal complication after thrombolytic therapy for acute myocardial infarction. Arch Intern Med. 1998;158:1575.
44. Adorati M, Pizzolitto S, Franzon R, et al. Cholesterol embolism and acute interstitial nephritis: two adverse effects of streptokinase thrombolytic therapy in the same patient. Nephrol Dial Transplant. 1998;13:1262-1264.
45. Funabiki K, Masuoka H, Shimizu H, et al. Cholesterol crystal embolization (CCE) after cardiac catheterization: a case report and a review of 36 cases in the Japanese literature. Jpn Heart J. 2003;44:767-774.
46. Hagiwara N, Toyoda K, Nakayama M, et al. Renal cholesterol embolism in patients with carotid stenosis: a severe and underdiagnosed complication following cerebrovascular procedures. J Neurol Sci. 2004;222:109-112.
47. Manganoni AM, Venturini M, Scolari F, et al. The importance of skin biopsy in the diverse clinical manifestations of cholesterol embolism. Br J Dermatol. 2004;150:1230-1231.
48. Moldveen-Geronimus M, Merriam JC. Cholesterol embolization. From pathological curiosity to clinical entity. Circulation. 1967;35: 946-953.
49. Hyman BT, Landas SK, Ashman RF, et al. Warfarin-related purple toes syndrome and cholesterol microembolization. Am J Med. 1987;82:1233-1237.
50. Falanga V, Fine MJ, Kapoor WN. The cutaneous manifestations of cholesterol crystal embolization. Arch Dermatol. 1986;122:1194-1198.
51. Kalter DC, Rudolph A, McGavran M. Livedo reticularis due to multiple cholesterol emboli. J Am Acad Dermatol. 1985;13:235-242.
52. Peat NS, Mathieson PW. Cholesterol emboli may mimic systemic vasculitis. BMJ. 1996; 313:546-547.
53. Taylor NS, Gueft B, Lebowich RJ. Atheromatous embolization: a cause of gastric ulcers and small bowel necrosis. Gastroenterology. 1964;47:97-103.
54. Carvajal JA, Anderson WR, Weiss L, et al. Atheroembolism. An etiologic factor in renal insufficiency, gastrointestinal hemorrhages, and peripheral vascular diseases. Arch Intern Med. 1967;119:593-599.
55. Rushovich AM. Perforation of the jejunum: a complication of atheromatous embolization. Am J Gastroenterol. 1983;78:77-82.
56. Anderson WR, Braverman T. Colon perforation due to cholesterol embolism. Hum Pathol. 1991;22:839-841.
57. Probstein JG, Joshi RA, Blumenthal HT. Atheromatous embolization; an etiology of acute pancreatitis. AMA Arch Surg. 1957;57:566-571.
58. Orvar K, Johlin FC. Atheromatous embolization resulting in acute pancreatitis after cardiac catheterization and angiographic studies. Arch Intern Med. 1994;154:1755-1761.
59. Moolenaar W, Kreuning J, Eulderink F, et al. Ischemic colitis and acalculous necrotizing cholecystitis as rare manifestations of cholesterol emboli in the same patient. Am J Gastroenterol. 1989;84:1421-1422.
60. Thomas W, Zaret P. Cholesterol emboli causing acute gangrenous cholecystitis. Mt Sinai J Med. 1984;51:716-717.
61. Quintart C, Treille S, Lefebvre P, et al. Penile necrosis following cholesterol embolism. Br J Urol. 1997;80:347-348.
62. Mondragon P, Descombes E, Bollmann J, et al. Penile necrosis in a haemodialysis patient: a rare manifestation of cholesterol crystal embolism. Nephrol Dial Transplant. 1998;13:3233-3235.
63. Chomette G, Tranbaloc P, Auriol M. Acute adrenal insufficiency caused by cholesterol emboli. Arch Anat Cytol Pathol. 1985;33:181-183.
64. Trono R, Sutton C, Hollman J, et al. Multiple myocardial infarctions associated with atheromatous emboli after PTCA of saphenous vein grafts. A clinicopathologic correlation. Cleve Clin J Med. 1989; 56:581-584.
65. Keon WJ, Heggtveit HA, Leduc J. Perioperative myocardial infarction caused by atheroembolism. J Thorac Cardiovasc Surg. 1982; 84:849-855.
66. Teja K, Crampton RS. Intramural coronary arteritis from cholesterol emboli: a rare cause of unstable angina preceding sudden death. Am Heart J. 1985;110:168-170.
67. Sturgill BC, Netsky MG. Cerebral infarction by atheromatous emboli. Report of a case and review of the literature. Arch Pathol. 1963;76: 189-196.
68. Beal MF, Williams RS, Richardson EP, et al. Cholesterol embolism as a cause of transient ischemic attacks and cerebral infarction. Neurology. 1981;31:860-865.
69. Matsumura T, Matsumoto A, Ohno M, et al. A case of cholesterol embolism confirmed by skin biopsy and successfully treated with statins and steroids. Am J Med. 2006;331: 280-283.
70. Modi KS, Rao VK. Atheroembolic renal disease. J Am Soc Nephrol. 2001;12:1781-1787.
71. Maki T, Izumi C, Miyake M, et al. Cholesterol embolism after cardiac catheterization mimicking infective endocarditis. Intern Med. 2005;44:1060-1063.
72. Scolari F, Tardanico R, Zani R, et al. Cholesterol crystal embolism: a recognizable cause of renal disease. Am J Kidney Dis. 2000;36: 1089-1109.
73. Lye WC, Cheah JS, Sinniah R. Renal cholesterol embolic disease. Case report and review of the literature. Am J Nephrol. 1993;13: 489-493.
74. Thadhani RI, Camargo CA, Xavier RJ, et al. Atheroembolic renal failure after invasive procedures. Natural history based on 52 histologically proven cases. Medicine (Baltimore). 1995;74:350-358.
75. Dahlberg PJ, Frecentese DF, Cogbill TH. Cholesterol embolism: experience with 22 histologically proven cases. Surgery. 1989; 105:737-746.
76. Gore I, McCombs HL, Lindquist RL. Observations on the fate of cholesterol emboli. J Atheroscler Res. 1964;4:527-535.
77. Bell SP, Frankel A, Brown EA. Cholesterol emboli syndrome - uncommon or unrecognized? J R Soc Med. 1997;90:543-546.
78. Jones DB, Iannaccone PM. Atheromatous emboli in renal biopsies. An ultrastructural study. Am J Pathol. 1975;78:261-276.
79. Otken LB. Experimental production of atheromatous embolization. Arch Pathol. 1959;68: 685-689.
80. Warren BA, Vales O. The ultrastructure of the reaction of arterial walls to cholesterol crystals in atheroembolism. Br J Exp Pathol. 1976; 57:67-77.
81. Warren BA, Vales O. The ultrastructure of the stages of atheroembolic occlusion of renal arteries. Br J Exp Pathol. 1973;54:469-478.
82. Mann SJ, Sos TA. Treatment of atheroembolization with corticosteroids. Am J Hypertens. 2001;14:831-834.
83. Nakahama H, Sakaguchi K. Small doses oral corticosteroid treatment rapidly improved renal function in a patient with an acute aggravation of chronic renal failure due to cholesterol emboli. Nephrol Dial Transplant. 2001;16:872-873.
84. Erdim M, Tezel E, Biskin N. A case of skin necrosis as a result of cholesterol crystal embolization. J Plast Reconstr Aesthet Surg. 2006;59:429-432.
85. Koga J, Ohno M, Okamoto K, et al. Cholesterol embolization treated with corticosteroids-two case reports. Angiology. 2005;56: 497-501.
86. Vacher-Coponat H, Pache X, Dussol B, et al. Pulmonary-renal syndrome responding to corticosteroids: consider cholesterol embolization. Nephrol Dial Transplant. 1997;12: 1977-1979.
87. Piccoli GB, Fenoglio R, Colla L, et al. Cholesterol crystal embolism syndrome in dialysis patients: an emerging clinical diagnosis? Blood Purif. 2006;24:433-438.
88. Takahashi T, Konta T, Nishida W, et al. Renal cholesterol embolic disease effectively treated with steroid pulse therapy. Intern Med. 2003;42:1206-1209.
89. Boero R, Pignataro A, Rollino C, et al. Do corticosteroids improve survival in acute renal failure due to cholesterol atheroembolism? Nephrol Dial Transplant. 2000;15:441.
90. Yucel AE, Kart-Koseoglu H, Demirham B, et al. Cholesterol crystal embolization mimicking vasculitis: success with corticosteroid and cyclophosphamide therapy in two cases. Rheumatol Int. 2006;26:454-460.
91. Maeshima E, Yamada Y, Mune M, et al. A case of cholesterol embolism with ANCA treated with corticosteroid and cyclophosphamide. Ann Rheum Dis. 2001;60:726.
92. Tan J, Afzal I, Yeadon A, et al. Spontaneous cholesterol embolisation causing acute renal failure. Clin Exp Nehrol. 2007;11:235-237.
93. Kaufman JL, Stark K, Brolin RE. Disseminated atheroembolism from extensive degenerative atherosclerosis of aorta. Surgery. 1987;102: 63-70.
94. Hasegawa M, Kawashima S, Shikano M, et al. The evaluation of corticosteroid therapy in conjunction with plasma exchange in the treatment of renal cholesterol embolic disease. A report of 5 cases. Am J Nephrol. 2000;20:263-267.
95. Fabbian F, Catalano C, Lambertini D, et al. A possible role of corticosteroids in cholesterol crystal embolization. Nephron. 1999;83:189-190.
96. Stabellini N, Rizzioli E, Trapassi MR, et al. Renal cholesterol microembolism: is steroid therapy effective? Nephron. 2000;86:239-240.
97. Bruns FJ, Segel DP, Adler S. Control of cholesterol embolization by discontinuation of anticoagulant therapy. Am J Med Sci. 1978;275:105-108.
98. Pirson Y, Honhon B, Cosyns JP, et al. Cholesterol embolism in a renal graft after treatment with streptokinase. Br Med J (Clin Res Ed). 1988;296:394-395.
99. Queen M, Biem HJ, Moe GW, et al. Development of cholesterol embolization after intravenous streptokinase for acute myocardial infarction. Am J Cardiol. 1990;65:1042-1043.
100. Kawakami Y, Hirose K, Watanabe Y, et al. Management of multiple cholesterol embolization syndrome - a case report. Angiology. 1990;41:248-252.
101. Kurata T, Kurata M, Okada T. Cerivastatin induces carotid artery plaque stabilization independently of cholesterol lowering in patients with hypercholesterolaemia. J Int Med Res. 2001;29:329-334.
102. Akdim F, Van Leuven SI, Kastelein JJ, et al. Pleiotropic effects of statins: stabilization of the vulnerable atherosclerotic plaque? Curr Pharm Des. 2007;13:1003-1012.
103. Yonemura K, Ikegaya N, Fujigaki Y, et al. Potential therapeutic effect of simvastatin on progressive renal failure and nephrotic-range proteinuria caused by renal cholesterol embolism. Am J Med Sci. 2001;322:50-52.
104. Finch TM, Ryatt KS. Livedo reticularis caused by cholesterol embolization may improve with simvastatin. Br J Dermatol. 2000;143: 1319-1320.
105. Woolfson RG, Lachmann H. Improvement in renal cholesterol emboli syndrome after simvastatin. Lancet. 1998;351:1331-1332.
106. Scolari F, Ravani P, Pola A, et al. Predictors of renal and patient outcomes in atheroembolic renal disease: a prospective study. J Am Soc Nephrol. 2003;14:1584-1590.
107. Scolari F, Ravani P, Gaggi R, et al. The challenge of diagnosing atheroembolic renal disease: clinical features and prognostic factors. Circulation, 2007;116:298-304.
108. Rumpf KW, Schult S, Mueller GA. Simvastatin treatment in cholesterol emboli syndrome. Lancet. 1998;352:321-322.
109. Enomae M, Takeda S, Yoshimoto K, et al. Chronic cholesterol crystal embolism with a spontaneous onset, Intern Med. 2007;46:1123-1126.
110. Sanai T, Matsui R, Hirano T. LDL apheresis for cholesterol embolism following coronary artery bypass graft surgery - a case report. Angiology. 2006;57:379-382.
111. Tsunoda S, Daimon S. Miyazaki R, et al. LDL apheresis as intensive lipid-lowering therapy for cholesterol embolism. Nephrol Dial Transplant. 1999;14:1041-1042.
112. Tamura K, Umemura M, Yano H, et al. Acute renal failure due to cholesterol crystal embolism treated with LDL apheresis followed by corticosteroid and candesartan. Clin Exp Nephrol. 2003;7:67-71.
113. Elinav E, Chajek-Shaul T, Stern M. Improvement in cholesterol emboli syndrome after iloprost therapy. BMJ. 2002;324:268-269.
114. Fisher DF, Clagett GP, Brigham RA, et al. Dilemmas in dealing with the blue toe syndrome: aortic versus peripheral source. Am J Surg. 1984;148:836-839.
115. Wingo JP, Nix ML, Greenfield LJ, et al. The blue toe syndrome: hemodynamics and therapeutic correlates of outcome. J Vasc Surg. 1986;3:475-480.
116. Applebaum RM, Kronzon I. Evaluation and management of cholesterol embolization and the blue toe syndrome. Curr Opin Cardiol. 1996;11:533-542.
117. Friedman SG, Krishnasastry KV. External iliac ligation and axillary-bifemoral bypass for blue toe syndrome. Surgery. 1994;115:27-30.
118. Sharma PV, Babu SC, Shah PM, et al. Changing patterns of atheroembolism. Cardiovasc Surg. 1996;4:573-579.
119. Dolmatch BL, Rholl KS, Moskowitz LB, et al. Blue toe syndrome: treatment with percutaneous atherectomy. Radiology. 1989;173:799-804.
120. Clugston RA, Eisenhauer AC, Matthews RV. Atherectomy of the distal aorta using a "kissing-balloon" technique for the treatment of blue toe syndrome. AJR Am J Roentgenol. 1992;159:125-127.
121. Kumpe DA, Zwerdlinger S, Griffin DJ. Blue digit syndrome: treatment with percutaneous transluminal angioplasty. Radiology. 1988; 166:37-44.
122. Matchett WJ, McFarland DR, Eidt JF, et al. Blue toe syndrome: treatment with intraarterial stents and review of therapies. J Vasc Interv Radiol. 2000;11:585-592.
123. Renshaw A, McCowen T, Waltke EA, et al. Angioplasty and stenting is effective in treating blue toe syndrome. Vasc Endovascular Surg. 2002;36:155-159.
124. Cardaioli P, Rigatelli G, Arboit M, et al. Treatment of cholesterol crystal embolisation syndrome with filter-assisted stenting. J Cardiovasc Med (Hagerstown). 2007;8:953-955.
125. Wholey MH, Toursarkissian B, Postoak D, et al. Early experience in the application of distal protection devices in treatment of peripheral vascular disease of the lower extremities. Catheter Cardiovasc Interv. 2005;64:227-235.
126. Suri R, Wholey MH, Postoak D, et al. Distal embolic protection during femoropopliteal atherectomy. Catheter Cardiovasc Interv. 2006;67:417-422.
127. Edwards MS, Craven BL, Stafford J, et al. Distal embolic protection during renal artery angioplasty and stenting. J Vasc Surg. 2006;44:128-135.
128. Edwards MS, Corriere MA, Craven T, et al. Atheroembolism during percutaneous renal artery revascularization. J Vasc Surg. 2007;46: 55-61.
129. Yadav JS, Wholey MH, Kuntz RE, et al. Protected carotid-artery stenting versus endarterectomy in high-risk patients. N Engl J Med. 2004;351:1493-1501.
130. Al-Mubarak N, Colombo A, Gaines PA, et al. Multicenter evaluation of carotid artery stenting with a filter protection system. J Am Coll Cardiol. 2002;39:841-846.
131. Henry M, Henry I, Klonaris C, et al. Renal angioplasty and stenting under protection: the way for the future? Catheter Cardiovasc Interv. 2003;60:299-312.
132. Parodi JC, La Mura R, Ferreira LM. Safety maneuvers to prevent embolism complicating endovascular aortic repair. J Vasc Surg. 2002;36:1076-1078.